Clinical Trial

Exercise Capacity in Diseases and Health

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Exercise capacity is a key factor to evaluate and treat patients in different diseases (e.g. ischemic heart disease, chronic obstructive pulmonary disease, cystic fibrosis). The best way to measure exercise capacity is to perform a cardiopulmonary exercise testing. Normal/reference values in health and disease relate to specific population and subpopulations. The population in Israel is unique in its diversity. Objectives: Data collection of exercise capacity assessment in health and illness in the northern of Israel for future local database. Population: 500 Patients evaluated routinely in the exercise lab (pediatric cardiology institute) and healthy volunteers evaluated as controls. Study design: Prospective observational study. Participants will answer a health related questioner, undergo a physical examination, perform a cardiopulmonary exercise test on a treadmill or a cycle ergometer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2015-10-12; most recent amendment 2017-01-23.
Trial Details
NCT Number NCT02575469
Lead Sponsor Rambam Health Care Campus
Conditions Exercise Capacity
Enrollment 500 participants
Start Date 2017-10-01
Primary Completion 2035-10-01 (estimated)
Study Completion 2036-01-01 (estimated)
Updated on ClinicalTrials.gov 2017-01-24